Dr. Morie Gertz of the Mayo Clinic shares his overview of this year’s American Society of Hematology (ASH) meeting. He talks about Dr. Brian Durie’s discussion of three-drug treatment providing longer overall survival in newly diagnosed multiple myeloma patients versus two-drug treatment. He also discusses the recent advances in oral agents to treat multiple myeloma.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content